Tamar Securities’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2M | Buy |
64,859
+1,194
| +2% | +$464K | 3.06% | 9 |
|
|
2025
Q1 | $27.7M | Buy |
63,665
+24,109
| +61% | +$10.5M | 3.75% | 7 |
|
|
2024
Q4 | $14.6M | Buy |
39,556
+8,184
| +26% | +$3.02M | 2.01% | 24 |
|
|
2024
Q3 | $16.3M | Buy |
31,372
+3,842
| +14% | +$2M | 2.29% | 22 |
|
|
2024
Q2 | $14.9M | Buy |
27,530
+1,881
| +7% | +$1.02M | 2.42% | 16 |
|
|
2024
Q1 | $13.3M | Buy |
25,649
+568
| +2% | +$295K | 2.24% | 23 |
|
|
2023
Q4 | $11.8M | Buy |
25,081
+1,628
| +7% | +$768K | 2.32% | 22 |
|
|
2023
Q3 | $10.2M | Buy |
23,453
+2,675
| +13% | +$1.16M | 2.46% | 17 |
|
|
2023
Q2 | $9.23M | Buy |
20,778
+2,550
| +14% | +$1.13M | 2.27% | 21 |
|
|
2023
Q1 | $8.38M | Sell |
18,228
-525
| -3% | -$241K | 2.41% | 20 |
|
|
2022
Q4 | $9.62M | Buy |
18,753
+354
| +2% | +$182K | 3.05% | 15 |
|
|
2022
Q3 | $8.36M | Buy |
18,399
+967
| +6% | +$439K | 2.67% | 14 |
|
|
2022
Q2 | $8.41M | Sell |
17,432
-897
| -5% | -$433K | 2.76% | 14 |
|
|
2022
Q1 | $9M | Buy |
18,329
+451
| +3% | +$222K | 2.51% | 15 |
|
|
2021
Q4 | $8.29M | Sell |
17,878
-1,682
| -9% | -$780K | 2.44% | 13 |
|
|
2021
Q3 | $7.29M | Buy |
19,560
+1,901
| +11% | +$709K | 2.63% | 13 |
|
|
2021
Q2 | $6.74M | Buy |
17,659
+93
| +0.5% | +$35.5K | 2.6% | 16 |
|
|
2021
Q1 | $6.31M | Buy |
17,566
+2,546
| +17% | +$914K | 2.44% | 16 |
|
|
2020
Q4 | $4.82M | Buy |
15,020
+1,468
| +11% | +$471K | 2.74% | 15 |
|
|
2020
Q3 | $3.64M | Buy |
13,552
+7,821
| +136% | +$2.1M | 2.26% | 22 |
|
|
2020
Q2 | $1.51M | Buy |
+5,731
| New | +$1.51M | 1.2% | 29 |
|